yep at best potential for $2 million revenue, but Teleperinatal have to find those customers first which seems a little optimistic. The pricing at a max of $34 per month (if users take up the device component) seems very cheap, even more so then the previously indicated prices. Maybe a case of beggers cant be choosers.
What i like is now with 2 startups taking on the platform the change in business strategy is showing signs of life. I like the 'TaaS' bolt on approach for existing telehealth providers, it offers less upside but should allow the company to run a very lean business. If they can sign up a more substantial/established company we could see this snowball in 2021. Mayo and Joondalup are the assumed next targets (lets hope so) and would provide validation of the platform to give other providers confidence. However if i see an announcement mention the likes of Maven, Mahmee or Babyscripts i would be very excited.
- Forums
- ASX - By Stock
- HMD
- Ann: Partnership to Launch HeraCARE & HeraBEAT with Teleperinatal
Ann: Partnership to Launch HeraCARE & HeraBEAT with Teleperinatal, page-12
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.11M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.3¢ | $68.94K | 2.997M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1059614 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 40000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1059614 | 0.022 |
2 | 2500000 | 0.021 |
2 | 2000000 | 0.020 |
2 | 3750000 | 0.019 |
2 | 109214 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 40000 | 1 |
0.024 | 100000 | 1 |
0.025 | 500000 | 1 |
0.026 | 406429 | 2 |
0.031 | 1000 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
HMD (ASX) Chart |